
|Videos|December 24, 2019
Targeting CD38 in Relapsed/Refractory Multiple Myeloma
Multiple Myeloma
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
PHERFLOT Trial: Perioperative Promise in HER2+ Esophagogastric Adenocarcinoma
2
Uncovering Clinical Risk Factors for T-DXd Pneumonitis in Metastatic Breast Cancer
3
Belzutifan Demonstrates Promise in Von Hippel-Lindau Disease
4
Glofitamab Plus Polatzumab Vedotin Demonstrates High Early Efficacy in LBCL
5





































